Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q14393
UPID:
GAS6_HUMAN
Alternative names:
AXL receptor tyrosine kinase ligand
Alternative UPACC:
Q14393; B3KRQ7; B3KVL4; E9PBL7; Q6IMN1; Q7Z7N3
Background:
Growth arrest-specific protein 6, also known as the AXL receptor tyrosine kinase ligand, plays a pivotal role in cell growth, survival, adhesion, and migration. It acts as a ligand for tyrosine-protein kinase receptors AXL, TYRO3, and MER, influencing endothelial cell survival, cytokine signaling, hepatic regeneration, and more. Additionally, it facilitates viral entry through apoptotic mimicry, impacting infections like Dengue and Ebola.
Therapeutic significance:
Understanding the role of Growth arrest-specific protein 6 could open doors to potential therapeutic strategies.